The latest news, stories and exciting findings from across the Oxford cancer research community
21 September 2023
Oxford’s first precision prevention cancer trial in people with Li Fraumeni Syndrome will also shed light on the mechanisms of cancer development in the general population
Congratulations to Cancer Science DPhil Student, Giampiero Valenzano: voted lead scientist of ‘I’m a Scientist’s’ Cancer Zone
19 September 2023
‘I’m a Scientist’ is a student-led STEM enrichment activity, which connects school students with scientists through energetic, real-time text-based chats.
11 September 2023
A study led by the Mead Group has demonstrated a previously unknown effect of chronic inflammation on TP53-mutant blood stem cells, shedding light on the progression of leukaemia.
5 September 2023
Oxford Cancer will host workshop on patient priorities for those with HCC (hepato-cellular carcinoma).
24 August 2023
A team of researchers led by the Nuffield Department of Primary Care Health Sciences, have developed a new model that reliably predicts a woman's likelihood of developing and then dying of breast cancer within a decade.
22 August 2023
The CRUK Oxford Centre - Oxford Cancer Symposium is the crowning event in the Oxford Cancer calendar. With approximately 300 people attending in person each year, it provides an opportunity for our members to network and build new collaborations.
Double funding success to improve detection and risk classification of myeloproliferative neoplasms (MPNs)
21 August 2023
Blood Cancer UK and Cancer Research UK recognise the need and impact of artificial intelligence approaches developed by Professor Daniel Royston and Professor Jens Rittscher for early detection and assessment of blood cancers.
Identification of a molecular signature that correlates with patient prognosis in SETD2-mutated cancers
21 August 2023
In a pan-cancer analysis spanning 24 different cancer types, researchers shed light on the relationship between SETD2, DNA methylation and cancer development.
Ludwig Oxford’s Richard White receives 2023 Outstanding Research award from the Society for Melanoma Research
18 August 2023
Richard White has received the 2023 Outstanding Research award from the Society for Melanoma Research.
15 August 2023
A new study from Professor Julia Hippisley-Cox and colleagues offers hope for the earlier detection of oesophageal cancer.
7 August 2023
The National Institute for Health and Care Research (NIHR) has announced a major investment in its Policy Research Units (PRUs). Researchers in the Nuffield Department of Primary Care Health Sciences at Oxford will play a key role in a new Unit focusing on the early detection of cancer.
25 July 2023
Research led by the Nuffield Department of Medicine has been published in Nature Scientific Reports, investing the effect of COVID-19 across the cancer population over the course of the pandemic. This analysis is the world’s largest and most comprehensive cancer evaluation showcasing the United Kingdom’s digital capabilities and the potential of population-scale cancer studies.
20 July 2023
New research, led by Professor Anindita Roy, is to be funded by families affected by childhood cancer through Children’s Cancer and Leukaemia Group (CCLG)'s Special Named Fund programme.
Oxford to launch UK’s first trials unit dedicated to conducting precision prevention and early detection studies
17 July 2023
Oxford researchers have been given a £1 million boost to support their strategy of developing cancer prevention treatments and early diagnostic tools for people at high risk of cancer.
12 July 2023
A new research project, led by Dr Toral Gathani and funded by Cancer Research UK, aims to shed light on the variation in breast cancer in different ethnic minority groups.
11 July 2023
A team of Oxford researchers has discovered a link between immune cells known as monocytes in tumours and overall survival in patients with oesophageal cancer.
4 July 2023
We were delighted to officially launch our Oxford Cancer Immuno-Oncology Network on the 23rd of June, with over 100 people in attendance and the luxury of convening at the Ashmolean Museum.
30 June 2023
New research led by Dr Johanna Michl and Professor Pawel Swietach has solved the longstanding mystery of how cancer cells are able to maintain a relatively alkaline intracellular pH, despite being surrounded by an acidic environment.
15 June 2023
David Hunter, Richard Doll Professor of Epidemiology and Medicine at Oxford Population Health, has been appointed as a Companion of the Order of Australia in the Australian King’s Birthday Honours List.
Women diagnosed with early breast cancer today are much less likely to die from the disease than 20 years ago
14 June 2023
A study conducted by researchers at Oxford Population Health has found that women who are diagnosed with early stage breast cancer today are 66% less likely to die from the disease within five years of diagnosis than they were 20 years ago.